WalsheC.Palliative care research: state of play and journal direction. Palliat Med2017; 31(1): 3–4.
2.
AbernethyAPCurrowDCFrithPet al. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ2003; 327(7414): 523–528.
3.
AbernethyAPMcDonaldCFFrithPAet al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet2010; 376(9743): 784–793.
4.
JohnsonMJKanaanMRichardsonGet al. A randomised controlled trial of three or one breathing technique training sessions for breathlessness in people with malignant lung disease. BMC Med2015; 13: 213.
5.
HigginsonIJBauseweinCReillyCCet al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med2014; 2(12): 979–987.
6.
HardyJQuinnSFazekasBet al. Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol2012; 30(29): 3611–3617.
7.
AgarMRLawlorPGQuinnSet al. Efficacy of oral risperidone, haloperidol, or placebo for symptoms of delirium among patients in palliative care: a randomized clinical trial. JAMA Intern Med2017; 177(1): 34–42.